Search

everythinglearnresearchcommunity

for

Search:↓

Disruption of glycinergic circuits increases pain sensitivity, suggesting new pain treatment options.

Carriers of a specific gene mutation have subtle skin changes without visible symptoms.

ODC transgenic mice can model human hair loss with skin lesions.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

Many medications may be linked to cognitive disorders, but most lack warnings on labels.

Isolated patchy heterochromia with pili annulati can occur without other health issues.

Post-drug syndromes are often overlooked, and better systems and education are needed to improve drug safety.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Nicotine may help treat both Parkinson's disease and infertility.

Deep Brain Stimulation helps manage Parkinson's symptoms when medication isn't enough.

An elderly man with skin amyloidosis and abnormal blood proteins was monitored without finding widespread disease after 18 months.

A certain gene variation can affect protein production and is linked to male pattern baldness.

Autoimmune Polyendocrine Syndromes involve specific combinations of autoimmune diseases.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

A brain-produced steroid causes increased scratching in mice with a skin condition similar to eczema.

Myotonic dystrophy may be classified as a segmental progeroid disorder.

A new patch can deliver stable antibodies over time for potential HIV treatment.

A 6-year-old boy developed excessive hair growth after taking diazoxide for low blood sugar.

Multitarget drugs are needed to better treat complex diseases.

Finasteride treatment for three years changes certain polyamine levels in the blood but not in urine.

THH and PAD type III appear together early in hair growth, but deiminated THH appears later, suggesting another factor is involved.

Four new cases of Bachmann-Bupp syndrome suggest potential for targeted treatment.

Clozapine levels in hair reflect dosage and bind more to pigmented hair.

Finasteride affects brain processes related to neurotransmission and metabolism, potentially helping with neuropsychiatric conditions.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Poly(ADP-ribose) synthesis is linked to skin cell differentiation.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.